Furthermore, it is worth noting that the expression of the IGFBP3 gene was downregulated in this type of SCAP treatment, and a recent study by Aizawa et al. in a mouse model showed that IGFBP3 is required for pre-odontoblast differentiation [96]. Here, IGFBP3 is linked to syringocystadenoma papilliferum.